HRSA Publishes New FAQ on Controversial 340B Rebate Pilot Program

HRSA recently published an FAQ addressing various stakeholder inquiries about its 340B rebate pilot program.
The Health Resources and Services Administration (HRSA) recently published an FAQ responding to stakeholder questions about its contentious new 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Court Schedules Late-October Oral Arguments for Drugmaker 340B Rebate Appeals

A Washington, D.C. federal appeals court scheduled oral arguments for drugmakers' 340B rebate appeals.
A federal appeals court recently scheduled late-October oral arguments for the pivotal legal battle over 340B rebate models, but hospitals [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

Is Your 340B Partner a Good Fit? Look for These Signs

SPONSORED CONTENT

Whether it’s new manufacturer restrictions affecting script and data qualification, amended state laws or regulations, or updated audit guidelines, the 340B landscape is constantly evolving. So, it’s no surprise that managing an organization’s 340B program is not easy

Read More »

Health System, Insurer Appear to Settle Lawsuit Alleging Medicare Advantage 340B Underpayments

Humana and an Alabama health system jointly asked a federal court to dismiss their ongoing litigation related to Medicare Advantage 340B payments.
An Alabama health system and a large health insurer appear to have reached a settlement over allegations that the insurer’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Six Drugmakers to Refund 340B Covered Entities for Overcharges

Six drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2019 and 2025.
Several drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2019 and 2025, following recalculations of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B INDUSTRY LEADER SPOTLIGHT

Stephanie Blaskoski, Regional Manager, SunRx

Stephanie Blaskoski

Q: Where did you grow up?

I grew up in the suburbs of Atlanta.

Q: Where did you go to college?

I received my Bachelor of Science in Biomedical Sciences from Auburn University.

Q: What are your favorites?

Food:  Probably ice cream!

Movie:  Avengers: Endgame

Musicians: I love most music- anything from country to

Read More »

Federal Judge Rejects Health System’s Bid for Interest on 340B Medicare Lump Sum Repayments

A federal district judge in Washington, D.C. ruled that an Alabama health system is not entitled to interest payments on CMS' 340B lump sum repayment remedy.
A federal judge in Washington, D.C. has rejected a University of Alabama Health System lawsuit seeking interest on Medicare’s lump [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Lilly Looks to Align U.S. Drug Prices with Other Nations Under Trump’s MFN Plan, Cites 340B ‘Abuse’ as Factor in Higher Costs 

Eli Lilly recently announced it’s working on certain pharmaceutical pricing changes to comply with President Donald Trump’s "most-favored nation" executive order.
An Indiana-based pharmaceutical giant recently announced that it’s working to align its U.S. drug prices with those paid by other [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two Drugmakers Sue Maine Over 340B Contract Pharmacy Law; Key Lawmaker Condemns Move

Drugmakers AbbVie and Novartis recently challenged Maine's 340B contract pharmacy access law in federal court.
Two major drugmakers recently filed lawsuits challenging Maine’s new 340B contract pharmacy access law, drawing sharp criticism from an influential [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novartis Exempts South Dakota, Colorado from 340B Contract Pharmacy Restrictions

Novartis recently exempted North Dakota and Colorado from its 340B contract pharmacy restrictions.
A Swiss pharmaceutical giant this week announced new 340B contract pharmacy restriction exemptions for two states that recently enacted contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live